A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00664898 · COMPLETED
Trial details
- NCT number
- NCT00664898
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-04-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.